Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2020. Start Trial.
Date Value
October 08, 2026 5.994
October 07, 2026 6.227
October 06, 2026 6.252
October 05, 2026 6.042
October 02, 2026 6.111
October 01, 2026 6.018
September 30, 2026 6.270
September 29, 2026 6.327
September 28, 2026 6.449
September 25, 2026 6.330
September 24, 2026 6.478
September 23, 2026 6.163
September 22, 2026 6.222
September 21, 2026 6.168
September 18, 2026 6.094
September 17, 2026 6.089
September 16, 2026 6.004
September 15, 2026 5.879
September 14, 2026 5.638
September 11, 2026 5.765
September 10, 2026 5.731
September 09, 2026 5.867
September 08, 2026 5.881
September 04, 2026 5.888
September 03, 2026 6.089
Date Value
September 02, 2026 6.096
September 01, 2026 6.088
August 31, 2026 6.16
August 28, 2026 6.262
August 27, 2026 6.295
August 26, 2026 6.115
August 25, 2026 6.144
August 24, 2026 6.122
August 21, 2026 6.256
August 20, 2026 6.256
August 19, 2026 5.892
August 18, 2026 5.680
August 17, 2026 5.783
August 14, 2026 5.867
August 13, 2026 5.882
August 12, 2026 5.828
August 11, 2026 5.889
August 10, 2026 5.900
August 07, 2026 5.812
August 06, 2026 5.668
August 05, 2026 5.658
August 04, 2026 5.640
August 03, 2026 5.642
July 31, 2026 5.386
July 30, 2026 5.497

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Evotec SE 0.7188
Gerresheimer AG 0.8885
Lifecore Biomedical, Inc. --
Mesa Laboratories, Inc. 3.815
Repligen Corp. 4.615

Price to Book Value Related Metrics